Management of hepatocellular carcinoma in renal transplant recipients

Journal of Surgical Oncology

Volumn 87, Issue 3, 2004, Pages 139-142

  Chok, Kenneth S ^a   Lam, Chi Ming ^a   Li, Fu Keung ^a   Ng, Kelvin K ^a   Poon, Ronnie T ^a   Lo, Chung Mau ^a   Fan, Sheung Tat ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Hepatectomy; Hepatocellular carcinoma; Renal transplantation; TOCE

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AGED; ARTICLE; CADAVER; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CASE REPORT; CHEMOEMBOLIZATION; ECHOGRAPHY; ENDEMIC DISEASE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HONG KONG; HUMAN; KIDNEY TRANSPLANTATION; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; MALIGNANT TRANSFORMATION; PATHOGENESIS; PRIORITY JOURNAL; SURVIVAL RATE; TRANSARTERIAL OILY CHEMOEMBOLIZATION; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HEPATECTOMY; HEPATITIS B, CHRONIC; HUMANS; KIDNEY TRANSPLANTATION; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 4444253523     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20098     Document Type: Article

References (15)

1. Penn I, Hammond W, Brettschneider L, et al.: Malignant lymphomas in transplantation patients. Transplant Proc 1969;1:106-112.
2. Penn I: Malignancy. Surg Clin North Am 1994;74:1247-1257.
3. Imanishi M, Kunikata S, Akiyama T, et al.: Study on the seven cases of malignant tumour after renal transplantation in our institution and statistic data of malignant tumour after renal transplantation in Japan. Ishoku (Jpn J Transplant) 1996;13:100-107.
4. Birkeland SA, Storm HH, Lamm LU, et al.: Cancer risk after renal transplantation in the Nordic countries. 1964-1986. Int J Cancer 1995;60:183-189.
5. Leung NW: Patterns of viral hepatitis in Hong Kong. Br J Hosp Med 1997;58:166-169.
6. Tang S, Lo CM, Chan TM, et al.: Early detection of hepatocellular carcinoma in hepatitis-B-positive renal transplant recipients. J Surg Oncol 1999;72:99-101.
7. Saeian K, Franco J, Komorowski RA, et al.: Hepatocellular carcinoma after renal transplantation in the absence of cirrhosis or viral hepatitis: A case series. Liver Transpl Surg 1999;5:46-49.
8. Tang TC, Shu KH, Cheng CH, et al.: Malignancy following renal transplantation. Chung Hua I Hsuch Tsa Chih [Taipei] 1998;61:281-288.
9. Poon RT, Fan ST, Lo CM, et al.: Improving survival results after resection of hepatocellular carcinoma: A prospective study of 377 patients over 10 years. Ann Surg 2001;234:63-70.
10. Ono Y, Ohshima S, Hanai S, et al.: A kidney transplant patient with hepatocellular carcinoma. Transplantation 1984;37:620-621.
11. Yuen MF, Cheng CC, Lauder IJ, et al.: Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 2000;31:330-335.
12. Kay J, Chow WH, Chan TM, et al.: Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: A randomized controlled trial. JAMA 2003;289:553-558.
13. Lam CM, Chan AO, Ho P, et al.: Different presentation of hepatitis B-related hepatocellular carcinoma in a cohort of 1863 young and old patients-implications for screening. Aliment Pharmacol Ther 2004;19:771-777.
14. Fornairon S, Pol S, Legendre C, et al.: The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection. Transplantation 1996;62:297-299.
15. Collier J, Sherman M. Screening for hepatocellular carcinoma. Hepatology 1998;27:273-278.